Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

23.57
-2.5600-9.80%
Volume:3.31M
Turnover:81.37M
Market Cap:17.39B
PE:-76.03
High:26.23
Open:26.18
Low:23.52
Close:26.13
Loading ...

Why Summit Therapeutics Inc. (SMMT) Skyrocketed On Monday?

Insider Monkey
·
Yesterday

Summit Therapeutics (NasdaqGM:SMMT) Welcomes Robert LaCaze As New Chief Commercial Officer

Simply Wall St.
·
Yesterday

Here's Why Summit Therapeutics Stock Soared 15% on Friday

Zacks
·
14 Apr

Why Summit Therapeutics Inc. (SMMT) Went Up On Thursday?

Insider Monkey
·
11 Apr

Summit co-CEO option exercise ‘quite bullish,’ says Cantor Fitzgerald

TIPRANKS
·
11 Apr

Expert says Summit’s HARMONi-2 study could beat expectations, says Truist

TIPRANKS
·
11 Apr

Summit Therapeutics (SMMT) Gets a Buy from Truist Financial

TIPRANKS
·
10 Apr

We Think Summit Therapeutics (NASDAQ:SMMT) Can Easily Afford To Drive Business Growth

Simply Wall St.
·
05 Apr

U.K. New-Car Sales Rose in March as EV Registrations Surged, Industry Body SMMT Says

Dow Jones
·
04 Apr

Esperion Therapeutics (ESPR) Down 15.8% Since Last Earnings Report: Can It Rebound?

Zacks
·
03 Apr

Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report?

Zacks
·
28 Mar

UK car output dips as Trump auto tariffs loom

cityam
·
27 Mar

U.K., U.S. Auto Industries Need to Strike Mutually Beneficial Deal, SMMT Says -- Market Talk

Dow Jones
·
27 Mar

Summit Therapeutics Shares up 2.3% After Citigroup Upgrades to Buy From Neutral, Raises PT to $35 From $23

THOMSON REUTERS
·
26 Mar

BUZZ-Summit gains as Citigroup raises to 'buy' on cancer drug prospects

Reuters
·
26 Mar

Summit Therapeutics Raised to Buy From Neutral by Citigroup

Dow Jones
·
26 Mar

S&P 500 Futures Decline In Premarket Trading; GameStop, Summit Therapeutics Lead

Dow Jones
·
26 Mar

Summit Therapeutics Shares up 4% Premarket After Citigroup Ugrades to Buy From Neutral, Raises PT to $35 From $23

THOMSON REUTERS
·
26 Mar

Summit Therapeutics Inc : Citigroup Raises to Buy From Neutral; Raises Target Price to $35 From $23

THOMSON REUTERS
·
26 Mar

Citigroup Upgrades Summit Therapeutics to Buy From Neutral, Adjusts Price Target to $35 From $23

MT Newswires Live
·
26 Mar